NCGM, Inc.

NCGM, Inc.

NCGM, Inc. is a CLIA- and CAP-accredited molecular diagnostics laboratory delivering advanced NGS-based oncology testing. PlasmaSEQ™ is our comprehensive genomic profiling assay for multiple myeloma, detecting clinically relevant translocations, copy number alterations, and somatic mutations in a single test. It provides actionable insights to support diagnosis, risk stratification, treatment selection, and disease monitoring.